Interdisciplinary expert team statement on the treatment of multi-bed atherosclerotic disease — endorsed by Polish Cardiac Society, Polish Lipid Association, Polish Society of Diabetology, Polish Neurological Society, Polish Society of Nephrology

Atherosclerosis is a systemic disease which involves not only the coronary vessels but also occurs in other vascular beds (e.g., cervical, cerebral, and peripheral vessels), increasing cardiovascular risk. One of the causes of atherosclerosis is lipid disorders. In addition, other diseases, such as diabetes, chronic kidney disease, or familial hypercholesterolemia, accelerate the development of multi-bed (multilevel) atherosclerosis. Such patients are often treated by physicians of various specialties, and in our country there is no integrated system for managing these patients and their further treatment. This frequently results in the inability to achieve the therapeutic goals for low-density lipoprotein cholesterol set by the guidelines despite the availability of modern therapy for the treatment of lipid disorders in our country. The presented expert position paper postulates modification of the treatment of patients with multi-bed atherosclerosis by strengthening cooperation between physicians of many specialties (cardiologists, diabetologists, nephrologists, vascular surgeons, pediatricians, etc.) to improve the effectiveness of treatment and better educate the medical community and the treated patients.

Authors

Institutions

Publication Details

Journal
Kardiologia Polska
Published
2025-03-11
DOI
https://doi.org/10.33963/v.phj.105235
Citations
5
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
10.03
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Interdisciplinary expert team statement on the treatment of multi-bed atherosclerotic disease — endorsed by Polish Cardiac Society, Polish Lipid Association, Polish Society of Diabetology, Polish Neurological Society, Polish Society of Nephrology

Krzysztof Strojek, Adam Witkowski, Ryszard Gellert, Anetta Lasek‐Bal et al.
5 citations
Kardiologia Polska
Lipoproteins and Cardiovascular Health
10.03
article

Interdisciplinary expert team statement on the treatment of multi-bed atherosclerotic disease — endorsed by Polish Cardiac Society, Polish Lipid Association, Polish Society of Diabetology, Polish Neurological Society, Polish Society of Nephrology

Krzysztof Strojek, Adam Witkowski, Ryszard Gellert, Anetta Lasek‐Bal, Adam Kobayashi, Przemysław Mitkowski, Krzysztof Dyrbuś, Jarosław Sławek, Magdalena Krajewska, Filip M. Szymański, Piotr Jankowski, Mariusz Gąsior, Tomasz Stompór, Marek Gierlotka, Konrad Rejdak, Agnieszka Słowik, Grzegorz Dzida, Maciej Wiewióra, Robert Gil, Marcin Gruchała, Beata Naumnik, Marlena Broncel, Irina Kowalska, Wacław Kuczmik, Alina Kułakowska, Maciej Małecki, Maciej Banach
article en
5 citations

Abstract

Atherosclerosis is a systemic disease which involves not only the coronary vessels but also occurs in other vascular beds (e.g., cervical, cerebral, and peripheral vessels), increasing cardiovascular risk. One of the causes of atherosclerosis is lipid disorders. In addition, other diseases, such as diabetes, chronic kidney disease, or familial hypercholesterolemia, accelerate the development of multi-bed (multilevel) atherosclerosis. Such patients are often treated by physicians of various specialties, and in our country there is no integrated system for managing these patients and their further treatment. This frequently results in the inability to achieve the therapeutic goals for low-density lipoprotein cholesterol set by the guidelines despite the availability of modern therapy for the treatment of lipid disorders in our country. The presented expert position paper postulates modification of the treatment of patients with multi-bed atherosclerosis by strengthening cooperation between physicians of many specialties (cardiologists, diabetologists, nephrologists, vascular surgeons, pediatricians, etc.) to improve the effectiveness of treatment and better educate the medical community and the treated patients.

Kardiologia PolskaVol. 83(4)
John Paul II Catholic University of Lublin (PL), Poznan University of Medical Sciences (PL), Medical University of Lublin (PL), Jagiellonian University (PL), Johns Hopkins University (US), Medical University of Białystok (PL), Medical University of Silesia (PL), University of Opole (PL), Johns Hopkins Medicine (US), Military University of Technology in Warsaw (PL), Military Hospital (PK), Medical University of Lodz (PL), Ministry of Interior and Administration (PL), Silesian Center for Heart Disease (PL), Postgraduate School of Molecular Medicine (PL), Institute of Cardiology (PL), Polish Mother’s Memorial Hospital Research Institute (PL), Krakow Cardiovascular Research Institute (PL), University of Warmia and Mazury in Olsztyn (PL), AGH University of Krakow (PL), Cardinal Stefan Wyszynski University in Warsaw (PL), Gdańsk Medical University (PL)
Good health and well-being
Openalex Percentile: Top 2%
Lipoproteins and Cardiovascular Health
10.03
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.